Rus Eng
Main / Company's news / Pregabalin produced by GEROPHARM - a new domestic alternative to the original drug

Pregabalin produced by GEROPHARM - a new domestic alternative to the original drug

21 March 2016

GEROPHARM Group continues to saturate the Russian market with good-quality, effective and safe generics. The series, which was launched in 2013 and included such items like Levetinol® (INN: levetiracetam), Memantinol® (INN: memantine), Recognan® (INN: citicoline), was also enhanced with the analogue drug Pregabalin this spring. This is a modern drug produced for the treatment of severe neuropathic pain.

The mechanism of drug action is based on the ability to simulate neuronal activity and normalize the nerve cells’ excitability. Pregabalin is effective as adjunctive therapy in adults with partial convulsive attacks, occurred with or without secondary generalization, for the treatment of generalized anxiety disorder in adults and also for the treatment of fibromyalgia in adults. The effectiveness of Pregabalin for the treatment of neuropathic pain was observed in patients with diabetic neuropathy and postherpetic neuralgia. In addition to its unique mechanism of action that allows to use Pregabalin for the treatment of neuropathic pain, the drug also possesses favorable pharmacokinetic properties. With itslinear pharmacokinetics the drug can be easily dosed. GEROPHARM produces the drug in 3 dosages: 75 mg, 150 mg, 300 mg.

Pregabalin is included in VED (Vital and essential drugs) list and it is also included in federal standards of specialized medical care.

You are a health care professional?

Go up